Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: Screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies

14Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Study Objectives: To examine in a subsample at the screening phase of a clinical trial of a β-amyloid (Aβ) antibody whether disturbed sleep and altered 24-hour rest/activity rhythms (RARs) may serve as markers of preclinical Alzheimer's disease (AD). Methods: Overall, 26 Aβ-positive (Aβ+) and 33 Aβ-negative (Aβ-) cognitively unimpaired participants (mean age = 71.3 ± 4.6 years, 59% women) from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) and the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, respectively, wore actigraphs for 5.66 ± 0.88 24-hour periods. We computed standard sleep parameters, standard RAR metrics (mean estimating statistic of rhythm, amplitude, acrophase, interdaily stability, intradaily variability, relative amplitude), and performed a novel RAR analysis (function-on-scalar regression [FOSR]). Results: We were unable to detect any differences between Aβ+ and Aβ- participants in standard sleep parameters or RAR metrics with our sample size. When we used novel FOSR methods, however, Aβ+ participants had lower activity levels than Aβ- participants in the late night through early morning (11:30 pm to 3:00 am), and higher levels in the early morning (4:30 am to 8:30 am) and from midday through late afternoon (12:30 pm to 5:30 pm; all p

References Powered by Scopus

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician

77569Citations
N/AReaders
Get full text

The clinical dementia rating (cdr): Current version and scoring rules

8097Citations
N/AReaders
Get full text

The role of actigraphy in the study of sleep and circadian rhythms

2207Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Circadian disruption and sleep disorders in neurodegeneration

44Citations
N/AReaders
Get full text

Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective

18Citations
N/AReaders
Get full text

Wrist accelerometry for monitoring dementia agitation behaviour in clinical settings: A scoping review

12Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Spira, A. P., Zipunnikov, V., Raman, R., Choi, J., Di, J., Bai, J., … Rosenberg, P. B. (2021). Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: Screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies. SLEEP Advances, 2(1). https://doi.org/10.1093/sleepadvances/zpab015

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

55%

Researcher 3

27%

Professor / Associate Prof. 2

18%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

38%

Psychology 3

23%

Neuroscience 3

23%

Mathematics 2

15%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free